BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 12620264)

  • 21. [Treatment of pemphigus with plasmapheresis].
    Friedman-Birnbaum R; Schechter Y; Bochner H
    Harefuah; 1989 Sep; 117(5-6):135-7. PubMed ID: 2485756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
    Egan CA; Meadows KP; Zone JJ
    Int J Dermatol; 2000 Mar; 39(3):230-5. PubMed ID: 10759969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of mucous membrane pemphigoid and pemphigus.
    Knudson RM; Kalaaji AN; Bruce AJ
    Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of therapeutic effect of extracorporeal detoxication in autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Romanenko AB; Chaiun OA; Dolia SV
    Vestn Dermatol Venerol; 1988; (7):6-11. PubMed ID: 3064487
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy.
    Tripodi G; Risso M; Tenerini L; Gandullia P; Castellano E; Rivabella L
    J Clin Apher; 2007 Feb; 22(1):26-30. PubMed ID: 17285616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current therapy of pemphigus vulgaris.
    Fellner MJ; Sapadin AN
    Mt Sinai J Med; 2001; 68(4-5):268-78. PubMed ID: 11514914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab in refractory pemphigus vulgaris.
    Sorce M; Aricò M; Bongiorno MR
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bullous autoimmune diseases of the oral mucosa].
    Vaillant L
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
    Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
    Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemphigus.
    Ioannides D; Lazaridou E; Rigopoulos D
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1478-96. PubMed ID: 18637862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
    Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
    Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorber.
    Günther C; Laske J; Frind A; Julius U; Pfeiffer C
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):661-3. PubMed ID: 18371053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I; Nitschke M; Rose C; Grabbe J; Zillikens D
    Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
    Reguiaï Z; Tchen T; Perceau G; Bernard P
    Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report.
    Khaddour HH; Zaher D; Kassem T; Hasan A
    J Med Case Rep; 2020 Jul; 14(1):109. PubMed ID: 32682443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical analysis of 64 cases of pemphigus].
    He Z; Wang B; Yu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):144-7. PubMed ID: 11367721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemphigus vulgaris: a therapeutic option for disease control.
    da Silva AV; Valones MA; Guimaraes RP; de Castro JF; Carvalho Ade A
    Gen Dent; 2008; 56(7):700-3. PubMed ID: 19014030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.